Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1983 Feb;48(2):229–237.

Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor.

M A Arnaout, N Dana, J Melamed, R Medicus, H R Colten
PMCID: PMC1453915  PMID: 6822401

Abstract

Quantitative studies of the interaction between a fragment of the third component of complement (C3b) and its receptor on human cells have been undertaken with a recently developed radioligand binding assay. Specific binding of fluid phase monomeric C3b was direct and saturable under low (mu = 0.0513) but not physiological (mu = 0.15) ionic strength. Dimeric C3b had a greater affinity for the C3b receptor at either ionic strength. Complexing of monomeric C3b with another protein (human IgG) did not result in increase in binding to human erythrocytes when compared with monomeric C3b alone. These data suggest that ionic forces are involved in C3b receptor-ligand interactions and that the stable C3b-receptor binding site is present in monomeric C3b. Furthermore they suggest that the greater affinity of dimeric or oligomeric C3b is a result of multimeric binding to preclustered C3b receptors. These findings provide an explanation for the relatively stable interaction of particle bound C3b and C3b receptor-bearing cells in the immune adherence reaction.

Full text

PDF
229

Images in this article

232Figure 1
on p.232
234Figure 3
on p.234
236Figure 6
on p.236

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnaout M. A., Melamed J., Tack B. F., Colten H. R. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer. J Immunol. 1981 Oct;127(4):1348–1354. [PubMed] [Google Scholar]
  2. Berger M., Gaither T. A., Hammer C. H., Frank M. M. Lack of binding of human C3, in its native state, to C3b receptors. J Immunol. 1981 Oct;127(4):1329–1334. [PubMed] [Google Scholar]
  3. Davies G. E., Stark G. R. Use of dimethyl suberimidate, a cross-linking reagent, in studying the subunit structure of oligomeric proteins. Proc Natl Acad Sci U S A. 1970 Jul;66(3):651–656. doi: 10.1073/pnas.66.3.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dixit R., Schneider R., Law S. K., Kulczycki A., Jr, Atkinson J. P. Ligand binding specificity of a rabbit alveolar macrophage receptor for C3b. J Biol Chem. 1982 Feb 25;257(4):1595–1597. [PubMed] [Google Scholar]
  5. Fearon D. T. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J Exp Med. 1980 Jul 1;152(1):20–30. doi: 10.1084/jem.152.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fearon D. T., Kaneko I., Thomson G. G. Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytes. J Exp Med. 1981 Jun 1;153(6):1615–1628. doi: 10.1084/jem.153.6.1615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fewtrell C., Metzger H. Larger oligomers of IgE are more effective than dimers in stimulating rat basophilic leukemia cells. J Immunol. 1980 Aug;125(2):701–710. [PubMed] [Google Scholar]
  8. Frade R., Strominger J. Interaction of particle-bound [125I]C3b, the third component of complement, with specific receptors on human B-lymphoblastoid cells (Raji). Immunol Lett. 1981 Aug;3(3):173–178. doi: 10.1016/0165-2478(81)90123-1. [DOI] [PubMed] [Google Scholar]
  9. Iida K., Mornaghi R., Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med. 1982 May 1;155(5):1427–1438. doi: 10.1084/jem.155.5.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  11. Lay W. H., Nussenzweig V. Receptors for complement of leukocytes. J Exp Med. 1968 Nov 1;128(5):991–1009. doi: 10.1084/jem.128.5.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McConahey P. J., Dixon F. J. A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol. 1966;29(2):185–189. doi: 10.1159/000229699. [DOI] [PubMed] [Google Scholar]
  13. Medicus R. G., Esser A. F., Fernandez H. N., Müller-Eberhard H. J. Native and activated properdin: interconvertibility and identity of amino- and carboxy-terminal sequences. J Immunol. 1980 Feb;124(2):602–606. [PubMed] [Google Scholar]
  14. Petty H. R., Smith L. M., Fearon D. T., McConnell H. M. Lateral distribution and diffusion of the C3b receptor of complement, HLA antigens, and lipid probes in peripheral blood leukocytes. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6587–6591. doi: 10.1073/pnas.77.11.6587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ross G. D., Polley M. J. Specificity of human lymphocyte complement receptors. J Exp Med. 1975 May 1;141(5):1163–1180. doi: 10.1084/jem.141.5.1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Segal D. M., Hurwitz E. Binding of affinity cross-linked oligomers of IgG to cells bearing Fc receptors. J Immunol. 1977 Apr;118(4):1338–1337. [PubMed] [Google Scholar]
  17. Tack B. D., Prahl J. W. Third component of human complement: purification from plasma and physicochemical characterization. Biochemistry. 1976 Oct 5;15(20):4513–4521. doi: 10.1021/bi00665a028. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES